204 related articles for article (PubMed ID: 23167339)
21. Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review.
Perez HC; Benavides X; Perez JS; Pabon MA; Tschen J; Maradei-Anaya SJ; Lopez L; Lozano E
Int J Dermatol; 2017 Apr; 56(4):370-378. PubMed ID: 27868187
[TBL] [Abstract][Full Text] [Related]
22. Sun protection factor reimbursement as a means to promote increased usage in an organ transplant recipient population.
O'Grady C; Roche D; Gilhooley E; MacMahon J; Awdeh F; Tobin AM
Photodermatol Photoimmunol Photomed; 2020 May; 36(3):244-245. PubMed ID: 31901202
[No Abstract] [Full Text] [Related]
23. Sirolimus and skin-cancer prevention in kidney transplantation.
Smak Gregoor PJ
N Engl J Med; 2012 Oct; 367(16):1565; author reply 1565-6. PubMed ID: 23075186
[No Abstract] [Full Text] [Related]
24. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
[TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
26. Belatacept reduces skin cancer risk in kidney transplant recipients.
Wang M; Mittal A; Colegio OR
J Am Acad Dermatol; 2020 Apr; 82(4):996-998. PubMed ID: 31589945
[No Abstract] [Full Text] [Related]
27. Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus.
Hoogendijk-van den Akker JM; Harden PN; Hoitsma AJ; Proby CM; Wolterbeek R; Bouwes Bavinck JN; de Fijter JW
J Clin Oncol; 2013 Apr; 31(10):1317-23. PubMed ID: 23358973
[TBL] [Abstract][Full Text] [Related]
28. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.
Bernat García J; Morales Suárez-Varela M; Vilata JJ; Marquina A; Pallardó L; Crespo J
Acta Derm Venereol; 2013 Jul; 93(4):422-7. PubMed ID: 23303600
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.
Yanik EL; Siddiqui K; Engels EA
Cancer Med; 2015 Sep; 4(9):1448-59. PubMed ID: 26108799
[TBL] [Abstract][Full Text] [Related]
31. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
32. Non-melanoma skin cancer risk in the Queensland renal transplant population.
Ramsay HM; Fryer AA; Hawley CM; Smith AG; Harden PN
Br J Dermatol; 2002 Nov; 147(5):950-6. PubMed ID: 12410706
[TBL] [Abstract][Full Text] [Related]
33. [Clinical study of non-melanoma skin cancer following human organ transplantation].
Fekecs T; Kádár Z; Battyáni Z; Kalmár-Nagy K; Szakály P; Wéber G; Horváth OP; Ferencz A
Magy Seb; 2010 Apr; 63(2):84-90. PubMed ID: 20400400
[TBL] [Abstract][Full Text] [Related]
34. [Skin cancers in kidney transplant recipients].
Bieryło A; Brzósko S; Laudańska E; Naumnik B
Wiad Lek; 2017; 70(1):68-73. PubMed ID: 28343197
[TBL] [Abstract][Full Text] [Related]
35. [Skin lesions in renal transplant recipients].
Myśliwiec H; Chodynicka B; Serwin AB
Wiad Lek; 2002; 55(3-4):214-20. PubMed ID: 12182007
[TBL] [Abstract][Full Text] [Related]
36. Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients.
van den Akker JM; Wetzels JF; Hoitsma AJ
Kidney Int; 2006 Oct; 70(7):1355-7. PubMed ID: 16912706
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.
Fryer AA; Ramsay HM; Lovatt TJ; Jones PW; Hawley CM; Nicol DL; Strange RC; Harden PN
Carcinogenesis; 2005 Jan; 26(1):185-91. PubMed ID: 15459020
[TBL] [Abstract][Full Text] [Related]
38. Counterpoint: sunscreen use is a safe and effective approach to skin cancer prevention.
Berwick M
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1923-4. PubMed ID: 17932338
[No Abstract] [Full Text] [Related]
39. Skin cancer surveillance in renal transplant recipients: re-evaluation of U.K. practice and comparison with Australian experience.
Garg S; Carroll RP; Walker RG; Ramsay HM; Harden PN
Br J Dermatol; 2009 Jan; 160(1):177-9. PubMed ID: 18798841
[TBL] [Abstract][Full Text] [Related]
40. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
